Acadia Healthcare Company, Inc. current report, 06 August 2019

Business Context and Reporting Period

This Form 8-K Current Report was filed by Acadia Healthcare Company, Inc. on August 6, 2019. The filing discloses the appointment of a new senior executive officer and the terms of the associated employment agreement.

Key Financial Metrics

This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.

Material Changes

The primary material change reported is the appointment of Laurence L. Harrod as Executive Vice President of Finance, effective August 12, 2019. Mr. Harrod joins from Universal Health Services, Inc., where he served as Senior Vice President of Finance, Behavioral Health.

Management Commentary and Compensation Terms

The filing details the employment agreement entered into with Mr. Harrod, which includes the following compensation components:

  • Base Salary: $555,000 annually, subject to discretionary increases.
  • Annual Bonus: Target of 85% of base salary, with a maximum of 200% of the target.
  • Equity Awards: A 2019 long-term incentive award with a target value of at least 220% of base salary. Future annual grants will be determined by the Compensation Committee.
  • Sign-on and Retention Bonuses: A one-time cash sign-on bonus of $200,000. Additionally, retention cash bonuses of $410,000 are payable on the first and second anniversaries of the effective date, contingent on continued employment.
  • Severance: In the event of termination without "cause" or resignation for "good reason," benefits include accrued salary and bonuses, a lump sum equal to one year of base salary plus target bonus, a pro-rated annual bonus, and 18 months of health and dental insurance premiums.
  • Restrictive Covenants: The agreement includes non-competition, non-solicitation, and non-disparagement clauses.

Investor Verification Checklist

  • Verify the total potential cash compensation value for the first two years, including the sign-on and retention bonuses.
  • Review the specific vesting schedules and performance metrics for the 220% equity award.
  • Confirm the definitions of "cause" and "good reason" within the full text of the Employment Agreement (Exhibit 10) to understand severance triggers.
  • Assess the impact of this executive transition on the company's financial strategy and reporting.